Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes

Background: Nedaplatin has demonstrated remarkable efficacy in combating various malignancies. However, the administration of nedaplatin has been associated with the induction of DNA damage within normal cells. Cilostazol is a phosphodiesterase III inhibitor with an antioxidant mechanism that could...

Full description

Saved in:
Bibliographic Details
Main Authors: Karem H. Alzoubi, Abeer M. Rababa’h, Omar F. Khabour, Fian Nuseir
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750025000460
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583829779382272
author Karem H. Alzoubi
Abeer M. Rababa’h
Omar F. Khabour
Fian Nuseir
author_facet Karem H. Alzoubi
Abeer M. Rababa’h
Omar F. Khabour
Fian Nuseir
author_sort Karem H. Alzoubi
collection DOAJ
description Background: Nedaplatin has demonstrated remarkable efficacy in combating various malignancies. However, the administration of nedaplatin has been associated with the induction of DNA damage within normal cells. Cilostazol is a phosphodiesterase III inhibitor with an antioxidant mechanism that could protect cells from genotoxicity. We aimed to evaluate the genotoxic effect of nedaplatin on cultured human lymphocytes and the potential protective effect of cilostazol on chromosomal damage induced by nedaplatin. Methods: The proposed nedaplatin’s genotoxic effect was studied in vitro by evaluating the frequencies of sister chromatid exchanges (SCEs) in human cultured lymphocytes. Both the mitotic and proliferative indices (MI and PI, respectively) were used to assess the cytotoxic effects of nedaplatin. Results: Nedaplatin significantly increased the frequency of SCEs compared to control and cilostazol-treated cells. The chromosomal injury induced by nedaplatin was significantly reduced by pretreatment of cells with cilostazol (P < 0.0001). Treating with cilostazol alone also reduced the frequency of SCEs, MI, and PI compared to the control group. Nedaplatin induced significant decreases in the MI and PI compared to the control group. Pretreatment with cilostazol partially debilitated the nedaplatin-induced changes in MI but not PI. Conclusion: Cilostazol ameliorated the genotoxicity of nedaplatin in cultured human lymphocytes.
format Article
id doaj-art-01a5e48399df40c9af6da2332bb0e481
institution Kabale University
issn 2214-7500
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj-art-01a5e48399df40c9af6da2332bb0e4812025-01-28T04:14:39ZengElsevierToxicology Reports2214-75002025-06-0114101928Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytesKarem H. Alzoubi0Abeer M. Rababa’h1Omar F. Khabour2Fian Nuseir3Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, The University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; Correspondence to: Department of Clinical Pharmacy, Jordan University of Science and Technology, PO Box 3030, Irbid 22110, Jordan.Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; Division of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USADepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, JordanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid, JordanBackground: Nedaplatin has demonstrated remarkable efficacy in combating various malignancies. However, the administration of nedaplatin has been associated with the induction of DNA damage within normal cells. Cilostazol is a phosphodiesterase III inhibitor with an antioxidant mechanism that could protect cells from genotoxicity. We aimed to evaluate the genotoxic effect of nedaplatin on cultured human lymphocytes and the potential protective effect of cilostazol on chromosomal damage induced by nedaplatin. Methods: The proposed nedaplatin’s genotoxic effect was studied in vitro by evaluating the frequencies of sister chromatid exchanges (SCEs) in human cultured lymphocytes. Both the mitotic and proliferative indices (MI and PI, respectively) were used to assess the cytotoxic effects of nedaplatin. Results: Nedaplatin significantly increased the frequency of SCEs compared to control and cilostazol-treated cells. The chromosomal injury induced by nedaplatin was significantly reduced by pretreatment of cells with cilostazol (P < 0.0001). Treating with cilostazol alone also reduced the frequency of SCEs, MI, and PI compared to the control group. Nedaplatin induced significant decreases in the MI and PI compared to the control group. Pretreatment with cilostazol partially debilitated the nedaplatin-induced changes in MI but not PI. Conclusion: Cilostazol ameliorated the genotoxicity of nedaplatin in cultured human lymphocytes.http://www.sciencedirect.com/science/article/pii/S2214750025000460NedaplatinCilostazolMitotic indexHuman cultured lymphocytesSister chromatid exchangesGenotoxicity
spellingShingle Karem H. Alzoubi
Abeer M. Rababa’h
Omar F. Khabour
Fian Nuseir
Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
Toxicology Reports
Nedaplatin
Cilostazol
Mitotic index
Human cultured lymphocytes
Sister chromatid exchanges
Genotoxicity
title Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
title_full Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
title_fullStr Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
title_full_unstemmed Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
title_short Cilostazol protective effect on nedaplatin-induced genotoxicity in cultured human lymphocytes
title_sort cilostazol protective effect on nedaplatin induced genotoxicity in cultured human lymphocytes
topic Nedaplatin
Cilostazol
Mitotic index
Human cultured lymphocytes
Sister chromatid exchanges
Genotoxicity
url http://www.sciencedirect.com/science/article/pii/S2214750025000460
work_keys_str_mv AT karemhalzoubi cilostazolprotectiveeffectonnedaplatininducedgenotoxicityinculturedhumanlymphocytes
AT abeermrababah cilostazolprotectiveeffectonnedaplatininducedgenotoxicityinculturedhumanlymphocytes
AT omarfkhabour cilostazolprotectiveeffectonnedaplatininducedgenotoxicityinculturedhumanlymphocytes
AT fiannuseir cilostazolprotectiveeffectonnedaplatininducedgenotoxicityinculturedhumanlymphocytes